Raia Drogasil S.A (RADL3) - Total Liabilities
Based on the latest financial reports, Raia Drogasil S.A (RADL3) has total liabilities worth R$18.23 Billion BRL (≈ $3.58 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore RADL3 net assets growth trend to track the company's year-over-year net asset growth rate.
Raia Drogasil S.A - Total Liabilities Trend (2000–2025)
This chart illustrates how Raia Drogasil S.A's total liabilities have evolved over time, based on quarterly financial data. See RADL3 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Raia Drogasil S.A Competitors by Total Liabilities
The table below lists competitors of Raia Drogasil S.A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Synovus Financial Corp
NYSE:SNV
|
USA | $54.65 Billion |
|
China Natl Chem Engineering Co
SHG:601117
|
China | CN¥174.47 Billion |
|
Lamb Weston Holdings Inc
NYSE:LW
|
USA | $5.58 Billion |
|
Artemis Gold Inc
V:ARTG
|
Canada | CA$1.46 Billion |
|
SM Energy Co
NYSE:SM
|
USA | $12.28 Billion |
|
Turkiye Is Bankasi AS Class C
IS:ISCTR
|
Turkey | TL4.88 Trillion |
|
Healthcare Realty Trust Incorporated
NYSE:HR
|
USA | $4.65 Billion |
|
BYD Electronic (International) Company Limited
F:4BY
|
Germany | €49.75 Billion |
Liability Composition Analysis (2000–2025)
This chart breaks down Raia Drogasil S.A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Raia Drogasil S.A worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.47 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.48 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.71 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Raia Drogasil S.A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Raia Drogasil S.A (2000–2025)
The table below shows the annual total liabilities of Raia Drogasil S.A from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | R$18.14 Billion ≈ $3.56 Billion |
+15.53% |
| 2024-12-31 | R$15.70 Billion ≈ $3.08 Billion |
+11.61% |
| 2023-12-31 | R$14.07 Billion ≈ $2.76 Billion |
+19.38% |
| 2022-12-31 | R$11.78 Billion ≈ $2.31 Billion |
+17.16% |
| 2021-12-31 | R$10.06 Billion ≈ $1.97 Billion |
+6.96% |
| 2020-12-31 | R$9.40 Billion ≈ $1.84 Billion |
+15.06% |
| 2019-12-31 | R$8.17 Billion ≈ $1.60 Billion |
+114.08% |
| 2018-12-31 | R$3.82 Billion ≈ $749.01 Million |
+18.77% |
| 2017-12-31 | R$3.21 Billion ≈ $630.62 Million |
+18.01% |
| 2016-12-31 | R$2.72 Billion ≈ $534.37 Million |
+33.34% |
| 2015-12-31 | R$2.04 Billion ≈ $400.76 Million |
+28.26% |
| 2014-12-31 | R$1.59 Billion ≈ $312.45 Million |
+23.72% |
| 2013-12-31 | R$1.29 Billion ≈ $252.55 Million |
+19.67% |
| 2012-12-31 | R$1.08 Billion ≈ $211.04 Million |
+11.21% |
| 2011-12-31 | R$967.13 Million ≈ $189.77 Million |
+198.80% |
| 2010-12-31 | R$323.67 Million ≈ $63.51 Million |
+1.35% |
| 2009-12-31 | R$319.35 Million ≈ $62.66 Million |
+32.58% |
| 2008-12-31 | R$240.87 Million ≈ $47.26 Million |
+21.07% |
| 2007-12-31 | R$198.94 Million ≈ $39.04 Million |
+12.01% |
| 2006-12-31 | R$177.62 Million ≈ $34.85 Million |
+12.27% |
| 2005-12-31 | R$158.21 Million ≈ $31.04 Million |
+69.45% |
| 2004-12-31 | R$93.37 Million ≈ $18.32 Million |
+34.56% |
| 2003-12-31 | R$69.39 Million ≈ $13.61 Million |
+13.56% |
| 2002-12-31 | R$61.10 Million ≈ $11.99 Million |
+21.05% |
| 2001-12-31 | R$50.48 Million ≈ $9.90 Million |
+2.27% |
| 2000-12-31 | R$49.36 Million ≈ $9.68 Million |
-- |
About Raia Drogasil S.A
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines in Brazil. The company sells its products through stores, telesales, and call centers. Raia Drogasil S.A. was founded in 1905 and is headquartered in São Paulo, Brazil.